Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphomaRoberta Soscia, Ilaria Del Giudice, Teresa Bellissimo et al.|Haematologica|2024Cited by 7
P1232: NON-INVASIVE MINIMAL RESIDUAL DISEASE ANALYSIS BY IMMUNOGLOBULIN GENE REARRANGEMENTS ON CIRCULATING TUMOR DNA PREDICTS THE OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMARoberta Soscia, Ilaria Del Giudice, Giovanni Manfredi Assanto et al.|HemaSphere|2023Cited by 1
Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL PatientsRiccardo Moia, Gianluca Gaïdano, Chiara Favini et al.|Blood|2022Cited by 0